Domain Informations
Advancedcscc.com lookup results from whois.markmonitor.com server:
- Domain created: 2018-01-04T18:21:08Z
- Domain updated: 2025-12-03T09:17:25Z
- Domain expires: 2028-01-04T18:21:08Z 1 Year, 361 Days left
- Website age: 8 Years, 3 Days
- Registrar Domain ID: 2208594750_DOMAIN_COM-VRSN
- Registrar Url: http://www.markmonitor.com
- Registrar WHOIS Server: whois.markmonitor.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1.2086851750
- Name server:
- NS1.MARKMONITOR.COM
- NS2.MARKMONITOR.COM
- NS3.MARKMONITOR.COM
- NS4.MARKMONITOR.COM
- NS5.MARKMONITOR.COM
- NS6.MARKMONITOR.COM
- NS7.MARKMONITOR.COM
Network
- inetnum : 192.103.124.0 - 192.103.125.255
- name : IGL-105
- handle : NET-192-103-124-0-1
- status : Direct Allocation
- created : 2020-01-23
- changed : 2020-01-23
Owner
- organization : Intouch Group, LLC
- handle : IGL-105
- address : Array,Overland Park,KS,66211,US
Abuse
- handle : BERKO19-ARIN
- name : Berkoz, Oguz
- phone : +1-913-956-4421
- email : [email protected]
Technical support
- handle : MCAMO6-ARIN
- name : McAmoil, Ed
- phone : +1-913-956-4421
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 192.103.124.138
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 192.103.124.138)
Spam Check (IP: 192.103.124.138)
Recent Searched Sites
› Pvl.ph (1 seconds ago) / US
› Maxgoshop.de (0 seconds ago) / DE
› Shopperboard.com (2 seconds ago) / US
› Autoimmunhilfe.de (0 seconds ago) / DE
› Ridgwayco.com (3 seconds ago) / US
› Budabet.com (0 seconds ago) / US
› Ping-awards.com (2 seconds ago) / FR
› Miniaturepaintingservice.us (6 seconds ago) / UA
› Lec-work.net (0 seconds ago) / JP
› Spiderconsulting.com (0 seconds ago) / US
› Sthlmkb.com (2 seconds ago) / US
› Meinunternehmenskonto.de (7 seconds ago) / DE
› 2.jxx7962s.cc (1 seconds ago) / HK
› 5678.net (2 seconds ago) / HK
› Green-bitcoin.com (0 seconds ago) / US
› Taikin.co.jp (4 seconds ago) / JP
› Groundlvl.com (0 seconds ago) / US
› Mp.ks.gov.ba (0 seconds ago) / BA
› Advancedcscc.com (0 seconds ago) / US
› Coronahc.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with advancedcscc.com on Search Engine
Advanced CSCC: What to Do When Surgery Just Isn’t …
2021-12-03 · Target Audience. This activity is intended for oncology, dermatology, and dermato-oncology clinicians who manage patients with cutaneous squamous cell carcinoma (CSCC). The goal of this activity is to …
Rmei.comWhat is Advanced CSCC (cutaneous squamous cell carcinoma)?
What is advanced CSCC? CSCC that has spread extensively or aggressively, or in some cases has not responded to multiple treatments and has returned repeatedly, is considered advanced because it has spread or cannot be cured by surgery or radiation. There are 2 forms: metastatic CSCC and locally advanced CSCC. Metastatic CSCC occurs when tumors ...
Libtayo.comIdentifying Locally Advanced CSCC - YouTube
Defining locally advanced cases of cutaneous squamous cell carcinoma (CSCC) can be challenging. Dr. Axel Hauschild, Professor of Dermatology and Head of Derm...
Youtube.comAdvanced Versus Metastatic CSCC - Cure Today
2019-12-23 · Advanced Versus Metastatic CSCC. December 23, 2019. EP. 1: Overview of Cutaneous Squamous Cell Carcinoma. EP. 2: Overview of Cutaneous Squamous Cell Carcinoma Management. EP. 3: Cutaneous Squamous Cell Carcinoma: What Is Immunotherapy? EP. 4: Experience With Immunotherapy in cSCC. EP. 5: Decision-Making Surrounding the Treatment …
Curetoday.comManaging Advanced CSCC with Multidisciplinary Teams - YouTube
When treating advanced cases of cutaneous squamous cell carcinoma (CSCC), evaluating all options in a multidisciplinary team (MDT) setting is critical. Prof....
Youtube.comPossible relevant diagnosis codes for cSCC
Possible relevant diagnosis codes for cSCC. Learn more about each diagnosis code and descriptor by selecting from the series options below. C44: Other and Unspecified Malignant Neoplasm of Skin 4. C44.12: Squamous Cell Carcinoma of Skin of Eyelid, Including Canthus 4. C44.129: Squamous Cell Carcinoma of Skin of Left Eyelid, Including Canthus 4.
Keytrudabillingcodes.comCheckpoint Blockade for Advanced cSCC: Exploring Newer Options
The emergence of checkpoint inhibitors for the treatment of advanced cSCC has expanded treatment options and allows us to serve a wider range of patients. A gap in care remains for cSCC that either does not respond to PD-1 inhibitor therapy or progresses after an initial response. For this reason, new medications designed to enhance the immune ...
Practicaldermatology.comAdvanced cutaneous squamous cell carcinoma: how is it defined …
The present study reviews the current definition of advanced cSCC and discusses the new systemic approaches, including checkpoint inhibitors. Curr Opin Oncol . 2019 Sep;31(5):461-468. doi: 10.1097/CCO.0000000000000566.
Pubmed.ncbi.nlm.nih.govWhat is Advanced CSCC? - LIBTAYO
Of course, advanced CSCC can look and feel different from person to person. Everyone has different areas that are affected and different problems andissues to deal with. Below the surface . With my most recent CSCC, it started in the lower layers of the skin. On the surface, there wasn’t a typical lesion or roughness. The skin looked normal. There wasn’t redness. It was thick and …
Libtayo.comLIBTAYO: Approved in locally advanced BCC and ... - Horizon …
Advanced CSCC Immune-mediated adverse reactions Dosing and patient support Please see additional Important Safety Information throughout and accompanying full Prescribing Information. †Based on IQVIA medical claims data from October 2018 to November 2020. Claims calibrated with actual vials sold.5 *LIBTAYO was FDA approved in advanced CSCC in September …
Horizonvirtualvenue.comAdvanced Cutaneous Squamous Cell Carcinoma in the Era of
Advanced cSCC is a life-threatening condition, and up until recently, no systemic therapies were FDA approved for this indication (Migden 2018). The emergence and recent approval of checkpoint inhibitors that block the PD-1/PD-L1 pathway for advanced cSCC represent a significant development for the treatment of patients with advanced cSCC (Kabir 2018; Ogata …
Mycme.comStudy Tests Novel Doublet Designed to Promote Immunity in cSCC
2020-04-13 · Cemiplimab-rwlc is the first and only treatment specifically approved for advanced cSCC and constitutes the standard of care. 4 However, a wider portfolio of effective systemic options is needed ...
Onclive.comCutaneoussquamouscellcarcinoma
Ter complete excision, advanced cSCC is difficult to treat. Until recently, no standard therapeutic regi-men for advanced cSCC exists. Traditional therapies include chemotherapy and EGFR-targeted therapy, but their clinical benefit remains modest and has been demonstrated mostly in retrospective studies. On the contrary, PD-1 inhibitors dramatically im-prove outcomes in …
Link.springer.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| payableapps.com | godaddy.com | -2 Years, -122 Days |
| listatrailer.com | godaddy.com | -3 Years, -160 Days |
| sweepstouch.com | wildwestdomains.com | 1 Year, 276 Days |
| pulaskibank.com | networksolutions.com | -3 Years, -238 Days |
| vijayengineerings.com | godaddy.com | -3 Years, -268 Days |
| lastday.club | whois.godaddy.com | -3 Years, -113 Days |
| avoyellesassessor.org | networksolutions.com | 336 Days |
| ulgatl.org | whois.godaddy.com | -2 Years, -337 Days |
| bantersa.com | domains.co.za | -3 Years, -221 Days |
| sequistvet.com | godaddy.com | -3 Years, -107 Days |